Isolation and characterization of factor I of the bovine complement system

American Journal of Veterinary Research

Volumn 64, Issue 8, 2003, Pages 989-993

  Menger, Marilyn ^a,b   Aston, W Peter ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; DISULFIDE; FIBRINOGEN; POLYPEPTIDE; PROPERDIN; TRYPSIN;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CATTLE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISULFIDE BOND; ERYTHROCYTE; ERYTHROCYTE GHOST; FRACTIONATION; GEL FILTRATION CHROMATOGRAPHY; ION EXCHANGE; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SPECIES DIFFERENCE;

ANIMALS; CATTLE; COMPLEMENT FACTOR I; ERYTHROCYTES; MOLECULAR WEIGHT;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0042121302     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.989     Document Type: Article

References (26)

1. Hein WR, MacKay CR. Prominence of gamma delta T cells in the ruminant immune system. Immunol Today 1991;12:30-34.
2. Howard CJ. Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum. Immunology 1980;41:561-568.
3. Nielson K, Duncan JR, Stemshorn B, et al. Relationship of humoral factors (antibody and complement) to immune responsiveness, resistance and diagnostic serology. Adv Exp Med Biol 1981;137:367-390.
4. Tabel H. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol 1982;4:329-335.
5. Boulard C. Degradation of bovine C3 by serine proteases from parasites Hypoderma lineatum (Diptera, Oestridae). Vet Immunol Immunopathol 1989;20:387-398.
6. Sim RB, Day AJ, Moffatt BE, et al. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol 1993;223:13-35.
7. Menger M, Aston WP. Isolation and Characterization of the third component of bovine complement. Vet Immunol Immunopathol 1985; 10:317-331.
8. Pang ASD, Aston WP. The alternative complement pathway in bovine serum: the isolation of a serum protein with factor B activity. Immunochemistry 1978;15:529-534.
9. Menger M, Aston WP. Factor D of the alternative pathway of bovine complement: isolation and characterization. Vet Immunol Immunopathol 1984;7:325-336.
10. Mhatre A, Aston WP. Isolation of bovine complement factor H. Vet Immunol Immunopathol 1987;14:357-375.
11. Nagasawa S, Ichthara C, Stroud RM. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b¢, as an intermediate cleavage product of C4b by C3b inactivation. J Immunol 1980;125:578-582.
12. Crossley LG, Porter RR. Purification of the human complement control protein C3b inactivator. Biochem J 1980;191:173-182.
13. Menger M, Sowery RD, Aston WP. Isolation and characterization of the eighth component of the bovine complement system. Am J Vet Res 1999;60:1474-1477.
14. Smith CA, Pangburn MK, Vogel CW, et al. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J Biol Chem 1984;259:4582-4588.
15. Harrison RA, Lachmann PJ. Complement technology. In: Weir DM, ed. Handbook of experimental immunology. 1. Immunochemistry. Oxford, England: Blackwell Scientific, 1986;39.1-39.49.
16. Dorval BL, Cosio FG, Birmingham DJ, et al. Human erythrocytes inhibit complement-mediated solubilization of immune complexes. J Immunol 1989;142:2721-2727.
17. Lambris JD, Ross GD. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres. J Immunol 1982;128:186-189.
18. Pillemer L, Blum L, Lepow IH, et al. The properdin system and immunity. 1. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 1954;120:279-285.
19. 2-macroglobulin family. J Immunol 1995;154:2164-2174.
20. Issac L, Isenman DE. Structural requirements for thioester bond formation in human complement component C3. Reassessment of the role of thioester bond integrity on the conformation of C3. J Biol Chem 1992;267:10062-10069.
21. Ogata RT, Low PJ, Kawakami M. Substrate specificities of the protease of mouse serum Ra-reactive factor. J Immunol 1995;154:2351-2357.
22. Soames CJ, Day AJ, Sim RB. Prediction from sequence comparisons of residues of factor H involved in the interaction with complement component C3b. Biochem J 1996;315:523-531.
23. Okada M, Lojima A, Takano H, et al. Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I. Mol Immunol 1993;30:841-848.
24. Sim RB. Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Biochem J 1985;232:883-889.
25. Di Carlo AL, Paape MJ, Miller RH. Reactivity of purified complement component C3b with bovine neutrophils and modulation of complement receptor 1. Am J Vet Res 1996;57:151-156.
26. Ezzell JL, Parker CJ. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity. Scand J Immunol 1992;36:79-87.